Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Sep 9, 2020 at 11:51 AM EDT

Is a Viable Treatment for Mesothelioma on the Horizon?

There is no cure for mesothelioma, but some companies are looking for better ways to treat the disease.

Chris Lange | Sep 9, 2020 at 11:29 AM EDT

Intra-Cellular Therapies Finds Euphoria in Bipolar Study Results

Intra-Cellular Therapies was one of the biggest winners on Wednesday after the company announced positive results from its late-stage clinical…

Chris Lange | Sep 9, 2020 at 10:10 AM EDT

Why This FDA Update Is a Huge Step Forward for Precision BioSciences

A key update from the FDA on its treatment for relapsed/refractory multiple myeloma boosted Precision BioSciences shares early on Wednesday.

Chris Lange | Sep 8, 2020 at 3:59 PM EDT

Co-Diagnostics Roars Back With New COVID-19 Test Deal

Co-Diagnostics announced Tuesday that it has entered into an agreement with Arches Research to expand Arches' COVID-19 testing services using…

Jon C. Ogg | Sep 8, 2020 at 3:27 PM EDT

What Does a Perfect COVID-19 Vaccine Actually Mean?

The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead…

Chris Lange | Sep 8, 2020 at 10:17 AM EDT

Are More Positive Results on the Way for Kamada’s COVID-19 Pneumonia Treatment?

Kamada has announced initial interim results from its ongoing midstage coronavirus study of its treatment of COVID-19 patients with pneumonia.

Chris Lange | Sep 8, 2020 at 9:52 AM EDT

Corbus Pharma Suffers Big Setback in Systemic Sclerosis Study

Corbus Pharmaceuticals has reported that its systemic sclerosis study failed to reach the endpoints, and investors were not pleased.

Chris Lange | Sep 3, 2020 at 12:22 PM EDT

Safety Concern Offsets Chronic Kidney Disease Study Positive Results

On Thursday, Akebia Therapeutics Inc. (NASDAQ: AKBA) announced topline results from the Phase 3 PRO2TECT studies evaluating the safety and…

Chris Lange | Sep 3, 2020 at 11:10 AM EDT

Auris Medical Makes Key Progress With Midstage Vertigo Trial

Auris Medical has reported topline data from its Phase 2 Travers trial with intranasal betahistine in vertigo.

Jon C. Ogg | Sep 2, 2020 at 7:27 PM EDT

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

America and the rest of the world is getting ready for a vaccine that will help protect public health against…

Chris Lange | Sep 1, 2020 at 3:50 PM EDT

Why This Gilead Deal Is Huge For Jounce Therapeutics

Jounce Therapeutics Inc. (NASDAQ: JNCE) made a massive gain on Tuesday after the company announced a licensing agreement with Gilead…

Chris Lange | Sep 1, 2020 at 10:45 AM EDT

Plus Therapeutics Takes a Big Step in the Fight Against Brain Cancer

Plus Therapeutics shares rallied on Tuesday after an FDA update on its treatment of patients with recurrent glioblastoma.

Jon C. Ogg | Sep 1, 2020 at 8:46 AM EDT

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but…

Chris Lange | Aug 31, 2020 at 1:45 PM EDT

Are Aimmune Shareholders Getting Enough in the Buyout?

The prize for Nestle in its acquisition of Aimmune Therapeutics is Palforzia, the world’s first treatment for a food allergy.

Chris Lange | Aug 31, 2020 at 11:01 AM EDT

What Akcea Shareholders Get in the Ionis Buyout

Akcea Therapeutics stock jumped on Monday after it was announced that Ionis Pharmaceuticals would be acquiring all of its outstanding…

1 … 42 43 44 45 46 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Is a Viable Treatment for Mesothelioma on the Horizon?

Intra-Cellular Therapies Finds Euphoria in Bipolar Study Results

Why This FDA Update Is a Huge Step Forward for Precision BioSciences

Co-Diagnostics Roars Back With New COVID-19 Test Deal

What Does a Perfect COVID-19 Vaccine Actually Mean?

Are More Positive Results on the Way for Kamada’s COVID-19 Pneumonia Treatment?

Corbus Pharma Suffers Big Setback in Systemic Sclerosis Study

Safety Concern Offsets Chronic Kidney Disease Study Positive Results

Auris Medical Makes Key Progress With Midstage Vertigo Trial

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

Why This Gilead Deal Is Huge For Jounce Therapeutics

Plus Therapeutics Takes a Big Step in the Fight Against Brain Cancer

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Are Aimmune Shareholders Getting Enough in the Buyout?

What Akcea Shareholders Get in the Ionis Buyout

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

Health and Healthcare Articles

All Health and Healthcare Articles

Is a Viable Treatment for Mesothelioma on the Horizon?

Intra-Cellular Therapies Finds Euphoria in Bipolar Study Results

Why This FDA Update Is a Huge Step Forward for Precision BioSciences

Co-Diagnostics Roars Back With New COVID-19 Test Deal

What Does a Perfect COVID-19 Vaccine Actually Mean?

Are More Positive Results on the Way for Kamada’s COVID-19 Pneumonia Treatment?

Corbus Pharma Suffers Big Setback in Systemic Sclerosis Study

Safety Concern Offsets Chronic Kidney Disease Study Positive Results

Auris Medical Makes Key Progress With Midstage Vertigo Trial

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

Why This Gilead Deal Is Huge For Jounce Therapeutics

Plus Therapeutics Takes a Big Step in the Fight Against Brain Cancer

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Are Aimmune Shareholders Getting Enough in the Buyout?

What Akcea Shareholders Get in the Ionis Buyout

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

Featured Reads

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes